| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/23/2002 | US6376186 Polynucleotide probes for detection and quantitation of staphylococcus |
| 04/23/2002 | US6376185 DNA sequences of genes from fimbriae d'escherichia coli strain DSM 6601 |
| 04/23/2002 | US6376184 Method for gene analysis |
| 04/23/2002 | US6376183 Hybridizing primer to target and effecting chain extension/chain termination, using primer selected from presynthesised set of walking primers of which annealing temperatures are raised and/or annealing properties improved |
| 04/23/2002 | US6376179 Fragmenting rna to produce plurality of rna fragments having freed terminal phosphates for further reaction, labeling fragments at freed terminal phosphates located at 3' end and/or 5' end of fragment |
| 04/23/2002 | US6376175 Contacting cell which is capable of expressing gene with amount of molecule effective to transcriptionally modulate expression of gene and thereby affect level of protein encoded by gene which is expressed by cell |
| 04/23/2002 | US6376174 Nucleic acid encoding Schwannomin-Binding-Proteins and products related thereto |
| 04/23/2002 | US6376172 Composition comprising mink lung cells and another cell type, suitable for detection of virus selected from influenza virus and parainfluenza virus |
| 04/23/2002 | US6375980 Stabilization of lipid:DNA formulations during nebulization |
| 04/23/2002 | US6375952 Isolated herpes simplex virus polypeptide |
| 04/23/2002 | US6375950 Methods for inducing T cell unresponsiveness to donor tissue or organ in a recipient with gp39 antagonists |
| 04/23/2002 | US6375949 Monoclonal antibody recognizing serum amyloid A |
| 04/23/2002 | US6375929 Gene therapy for inhibition of angiogenesis |
| 04/23/2002 | US6375818 Surfaces with reduced electroosmotic flow |
| 04/23/2002 | US6374683 Pipetter |
| 04/23/2002 | CA2322241A1 Antibiotic production |
| 04/23/2002 | CA2236616C Detection of nucleic acids by fluorescence quenching |
| 04/23/2002 | CA2221807C Method for producing phytase |
| 04/23/2002 | CA2203765C Cathepsin o2 protease |
| 04/23/2002 | CA2075847C Mycobacterium primers and probes |
| 04/23/2002 | CA2071196C Recombinant expression vectors and purification methods for thermus thermophilus dna polymerase |
| 04/23/2002 | CA2065361C Apparatus for genetic transformation |
| 04/18/2002 | WO2002031747A1 High throughput processing system and method of using |
| 04/18/2002 | WO2002031704A1 Interactive correlation of compound information and genomic information |
| 04/18/2002 | WO2002031511A2 Modulation of ligand binding/enzymatic activity of alpha beta proteins |
| 04/18/2002 | WO2002031207A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma |
| 04/18/2002 | WO2002031203A2 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 04/18/2002 | WO2002031202A2 High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds |
| 04/18/2002 | WO2002031201A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | WO2002031198A2 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | WO2002031193A1 Method of analyzing nucleic acid |
| 04/18/2002 | WO2002031192A1 Method of constructing self-assembly of probes and method of detecting the same |
| 04/18/2002 | WO2002031191A2 Dendritically amplified detection method |
| 04/18/2002 | WO2002031190A2 Methods of identification and isolation of polynucleotides containing nucleic acid differences |
| 04/18/2002 | WO2002031189A2 Model system for the vivo study of apoptosis |
| 04/18/2002 | WO2002031186A2 Method for the detection of cytosine methylations |
| 04/18/2002 | WO2002031182A2 Method and apparatus for reading reporter labeled beads |
| 04/18/2002 | WO2002031178A1 An artificial gene and vectors for expressing high-yield recombinant ovine interferon-tau in pichia pastoris |
| 04/18/2002 | WO2002031177A2 Method for synthesising peptides, peptide mimetics and proteins |
| 04/18/2002 | WO2002031173A2 Improved method for the biosynthesis of vitamin e |
| 04/18/2002 | WO2002031170A1 Method for circularizing adenoviral nucleic acid via homologous recombination |
| 04/18/2002 | WO2002031169A1 Method of preparing a eukaryotic viral vector |
| 04/18/2002 | WO2002031168A2 Minimal adenoviral vector and recombinant vaccines based thereon |
| 04/18/2002 | WO2002031167A1 Whisker-mediated transformation of embryogenic cotton suspension cultures |
| 04/18/2002 | WO2002031166A2 Artificial transcriptional factors and methods of use |
| 04/18/2002 | WO2002031165A1 Method of constructing dna mass having deletion mutation transferred thereinto and method of identifying protein-binding region |
| 04/18/2002 | WO2002031164A1 Farnesyl pyrophosphate synthase protein, nucleic acid and promoter region thereof |
| 04/18/2002 | WO2002031163A1 Novel adamts family polypeptide and gene encoding the same |
| 04/18/2002 | WO2002031162A2 Regulation of human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031161A2 Regulation of human phospholipase-like enzyme |
| 04/18/2002 | WO2002031160A2 Regulation of human phospholipase a2-like enzyme |
| 04/18/2002 | WO2002031159A1 Novel n-acetylglucosaminyltransferase and polynucleotide encoding the same |
| 04/18/2002 | WO2002031157A2 Shrimp alkaline phosphatase |
| 04/18/2002 | WO2002031156A2 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | WO2002031155A2 Gene cluster for ramoplanin biosynthesis |
| 04/18/2002 | WO2002031154A1 Bzip type transcripiton factors regulating the expression of rice storage protein |
| 04/18/2002 | WO2002031153A2 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains |
| 04/18/2002 | WO2002031152A2 Intracellular signaling molecules |
| 04/18/2002 | WO2002031151A2 Lipocalins |
| 04/18/2002 | WO2002031150A2 Human ion channel protein and polynucleotides encoding the same |
| 04/18/2002 | WO2002031149A2 Polyvalent cation-sensing receptor proteins in aquatic species |
| 04/18/2002 | WO2002031148A2 Mammalian wnt polypeptide-5 |
| 04/18/2002 | WO2002031147A2 Human transporter proteins and polynucleotides encoding the same |
| 04/18/2002 | WO2002031146A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | WO2002031145A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/18/2002 | WO2002031144A2 Identification of cytotoxic activity from the ink of aplysia punctata |
| 04/18/2002 | WO2002031143A2 Nucleic acid sequences encoding cmg proteins cmg proteins and methods for their use |
| 04/18/2002 | WO2002031142A2 Antisense nucleic acid against alphav integrin |
| 04/18/2002 | WO2002031141A2 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof |
| 04/18/2002 | WO2002031139A1 Compulsive transporter expression vector for organ infection |
| 04/18/2002 | WO2002031138A1 Paramyxovirus vector for transferring foreign gene into skeletal muscle |
| 04/18/2002 | WO2002031137A2 Cytomegalovirus intron a fragments |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031133A1 Subtilase variants |
| 04/18/2002 | WO2002031132A2 8843, a human dual specificity phosphatase family member and uses therefor |
| 04/18/2002 | WO2002031130A1 Manipulation of soluble carbohydrates |
| 04/18/2002 | WO2002031129A2 Human kinases and polynucleotides encoding the same |
| 04/18/2002 | WO2002031126A2 Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002031113A2 Enhanced selection of genetically modified pine embryogenic tissue |
| 04/18/2002 | WO2002031112A2 Enhanced transformation and regeneration of transformed embryogenic pine tissue |
| 04/18/2002 | WO2002031110A2 Hematopoietic stem cell gene therapy |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030987A1 Antihuman heme oxygenase-1 monoclonal antibody |
| 04/18/2002 | WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 04/18/2002 | WO2002030985A2 Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 04/18/2002 | WO2002030984A1 Human anti-epidermal growth factor receptor single-chain antibodies |
| 04/18/2002 | WO2002030982A2 Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use |
| 04/18/2002 | WO2002030981A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | WO2002030980A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 04/18/2002 | WO2002030979A2 Polypeptides homologous to thymosin, ephrin a receptors, and fibromodulin, and polynucleotides encoding same |
| 04/18/2002 | WO2002030978A1 Polypeptides, methods of making, and uses thereof |
| 04/18/2002 | WO2002030977A2 Egf motif protein, egfl6 materials and methods |
| 04/18/2002 | WO2002030974A2 Proteins and nucleic acids encoding same |
| 04/18/2002 | WO2002030972A2 Regulation of nf-at interacting protein nip 45 like protein |
| 04/18/2002 | WO2002030971A2 Basb205 polypeptides and polynucleotides coding therefor |
| 04/18/2002 | WO2002030970A2 Human histone deacetylase gene |
| 04/18/2002 | WO2002030968A1 Novel mite allergens and uses therefor |
| 04/18/2002 | WO2002030967A2 Novel compounds |
| 04/18/2002 | WO2002030966A2 Alzheimer's disease-associated proteins |